Aptevo Therapeutics Inc. (30) | Uncategorized (2)
- Amendment No. 2 to Rights Agreement, dated as of November 4, 2022, between the Company and Broadridge Corporate Issuer Solutions, Inc., as Rights Agent (Filed With SEC on November 4, 2022)
- Amendment No. 1 to Rights Agreement, dated as of November 5, 2021, between the Company and Broadridge Corporate Issuer Solutions, Inc., as Rights Agent (Filed With SEC on November 5, 2021)
